A selection of abstracts of clinically relevant papers from other journals. The abstracts on this page have been chosen and edited by John R. Radford.
Abstract
Botulinum toxin (BoNT) to facilitate 'muscle relaxation', in combination with a 'light' filler for 'dermal treatment' and a 'heavy' filler for 'lifting capacity'.
Main
Pickett A. Fac Dent J 2012; 3: 184–190
Not only are non-surgical facial aesthetic therapies increasingly being performed but there is an almost rapacious desire for them. For example, Asian people want 'more shaped features than a round lower face'. When considering BoNT, only type A products are licenced for aesthetic use in the UK and this is restricted to the management of glabellar lines. Botulinum toxin is not licenced for the management of masseteric hypertrophy and bruxism despite such treatments having favourable outcomes. Dermal fillers based on collagen are no longer available and have been replaced by hyaluronic acid products derived from bacteria. A cocktail of BoNT, hydroxyapatite filler, adrenaline and lidocaine 'is not to be recommended under any circumstances'.
Rights and permissions
About this article
Cite this article
Advances in non-surgical facial aesthetics. Br Dent J 213, 559 (2012). https://doi.org/10.1038/sj.bdj.2012.1104
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bdj.2012.1104
